- Home
- IAG vs CLDX Comparison
IAG vs CLDX Comparison
Compare IAG & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAG
- CLDX
- Stock Information
- Founded
- IAG 1990
- CLDX 1983
- Country
- IAG Canada
- CLDX United States
- Employees
- IAG N/A
- CLDX 160
- Industry
- IAG Precious Metals
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IAG Basic Materials
- CLDX Health Care
- Exchange
- IAG Nasdaq
- CLDX Nasdaq
- Market Cap
- IAG 3.2B
- CLDX 1.8B
- IPO Year
- IAG 1996
- CLDX 2008
- Fundamental
- Price
- IAG $5.71
- CLDX $27.02
- Analyst Decision
- IAG Buy
- CLDX Buy
- Analyst Count
- IAG 6
- CLDX 8
- Target Price
- IAG $7.40
- CLDX $64.83
- AVG Volume (30 Days)
- IAG 7.5M
- CLDX 1.1M
- Earning Date
- IAG 11-07-2024
- CLDX 11-06-2024
- Dividend Yield
- IAG N/A
- CLDX N/A
- EPS Growth
- IAG 420.20
- CLDX N/A
- EPS
- IAG 1.38
- CLDX N/A
- Revenue
- IAG $1,460,700,000.00
- CLDX $9,976,000.00
- Revenue This Year
- IAG $68.68
- CLDX N/A
- Revenue Next Year
- IAG $38.44
- CLDX N/A
- P/E Ratio
- IAG $4.51
- CLDX N/A
- Revenue Growth
- IAG 62.90
- CLDX 128.55
- 52 Week Low
- IAG $2.11
- CLDX $22.93
- 52 Week High
- IAG $6.37
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- IAG 58.53
- CLDX 49.11
- Support Level
- IAG $4.89
- CLDX $22.93
- Resistance Level
- IAG $5.88
- CLDX $28.15
- Average True Range (ATR)
- IAG 0.23
- CLDX 1.67
- MACD
- IAG 0.04
- CLDX 0.38
- Stochastic Oscillator
- IAG 82.32
- CLDX 78.35
About IAG Iamgold Corporation
Iamgold Corp is a mid-tier gold mining company. The company operating gold mines are divided into geographic segments such as Burkina Faso - Essakane mine, Canada - Doyon division, including Westwood mine. The company's s non-gold mine segments are the Cote Gold project, Exploration and evaluation and development, and Corporate - which includes royalty interests. The company generates the majority of its revenue from the Burkina Faso segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.